{"id": "385882", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-rating"], "versionId": "11", "lastUpdated": "2025-08-14T17:38:12.311Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p><b>Title: </b>Recommendation Rating: ADA Obesity Management Recommendation 8.16</p><br/><p><b>Rating for Recommendation: </b>Recommendation: ADA Obesity Management Recommendation 8.16</p><br/><table><tr><th>Concept</th><th>Summary</th><th>Rating</th></tr><tr><td>Rating System (coded as: rating-system from https://fevir.net/resources/CodeSystem/179423)</td><td>undefined</td><td>ADA Level of Evidence</td></tr><tr><td>Direction of Recommendation (coded as: direction-of-recommendation from https://fevir.net/resources/CodeSystem/179423)</td><td>undefined</td><td>Favors intervention (coded as: RJCS-2021 from https://fevir.net/resources/CodeSystem/27834)</td></tr><tr><td>Ratings (coded as: ratings from https://fevir.net/resources/CodeSystem/179423)</td><td>undefined</td><td>A</td></tr><tr><td>Certainty of Evidence (coded as: certainty-of-evidence from https://fevir.net/resources/CodeSystem/179423)</td><td>A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.</td><td>ADA Level of Evidence A</td></tr></table><br/></div>", "status": "generated"}, "title": "Recommendation Rating: ADA Obesity Management Recommendation 8.16", "citeAs": "Recommendation Rating: ADA Obesity Management Recommendation 8.16 [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 385882. Revised 2025-08-14. Available at: https://fevir.net/resources/ArtifactAssessment/385882. Computable resource at: https://fevir.net/resources/ArtifactAssessment/385882#json.", "content": [{"type": {"coding": [{"code": "rating-system", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Rating System"}]}, "classifier": [{"text": "ADA Level of Evidence"}], "freeToShare": true}, {"type": {"coding": [{"code": "strength-of-recommendation", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Strength of Recommendation"}]}, "freeToShare": true}, {"type": {"coding": [{"code": "direction-of-recommendation", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Direction of Recommendation"}]}, "classifier": [{"coding": [{"code": "RJCS-2021", "system": "https://fevir.net/resources/CodeSystem/27834", "display": "Favors intervention"}]}], "freeToShare": true}, {"type": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "summary": "A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.", "classifier": [{"text": "ADA Level of Evidence A"}], "freeToShare": true}, {"type": {"coding": [{"code": "ratings", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Ratings"}]}, "classifier": [{"text": "A"}], "freeToShare": true}], "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-description", "valueMarkdown": "An example using the ArtifactAssessment Resource for representation of the rating assigned to a recommendation."}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "relatesTo": [{"type": "derived-from", "targetReference": {"type": "ArtifactAssessment", "display": "Justification for Recommendation: ADA Obesity Management Recommendation 8.16", "reference": "ArtifactAssessment/179469"}}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "385882", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "ArtifactAssessment", "artifactReference": {"type": "Composition", "display": "Recommendation: ADA Obesity Management Recommendation 8.16", "reference": "Composition/179466"}}